G
Giuseppe Biondi-Zoccai
Researcher at Sapienza University of Rome
Publications - 916
Citations - 35049
Giuseppe Biondi-Zoccai is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Myocardial infarction & Percutaneous coronary intervention. The author has an hindex of 89, co-authored 799 publications receiving 30225 citations. Previous affiliations of Giuseppe Biondi-Zoccai include Catholic University of the Sacred Heart & University of Milan.
Papers
More filters
Journal ArticleDOI
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic.
Elissa Driggin,Mahesh V. Madhavan,Behnood Bikdeli,Taylor Chuich,Justin Laracy,Giuseppe Biondi-Zoccai,Tyler S. Brown,Caroline Der Nigoghossian,David A. Zidar,Jennifer Haythe,Daniel Brodie,Joshua A. Beckman,Ajay J. Kirtane,Gregg W. Stone,Harlan M. Krumholz,Sahil A. Parikh +15 more
TL;DR: The peer-reviewed and preprint literature pertaining to cardiovascular considerations related to COVID-19 are reviewed to highlight gaps in knowledge that require further study pertinent to patients, health care workers, and health systems.
Journal ArticleDOI
Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials.
Pierfrancesco Agostoni,Giuseppe Biondi-Zoccai,M. Luisa De Benedictis,Stefano Rigattieri,Marco Turri,Maurizio Anselmi,Corrado Vassanelli,Piero Zardini,Yves Louvard,Martial Hamon +9 more
TL;DR: A clear ongoing trend toward equalization of the two procedures, in terms of procedural success, is evident through the years, probably due to technologic progress of materials and increased operator experience.
Journal ArticleDOI
Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis
Tullio Palmerini,Giuseppe Biondi-Zoccai,Diego Della Riva,Christoph Stettler,Diego Sangiorgi,Fabrizio D'Ascenzo,Takeshi Kimura,Carlo Briguori,Manel Sabaté,Hyo-Soo Kim,Antoinette de Waha,Elvin Kedhi,Pieter C. Smits,Christoph Kaiser,Gennaro Sardella,Antonino G.M. Marullo,Ajay J. Kirtane,Martin B. Leon,Gregg W. Stone +18 more
TL;DR: In randomised studies completed to date, CoCr-EES has the lowest rate of stent thrombosis within 2 years of implantation and if confirmed in future randomised trials, represents a paradigm shift.
Journal ArticleDOI
Radial Versus Femoral Randomized Investigation in ST-Segment Elevation Acute Coronary Syndrome The RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) Study
Enrico Romagnoli,Giuseppe Biondi-Zoccai,Alessandro Sciahbasi,Luigi Politi,Stefano Rigattieri,Gianluca Pendenza,Francesco Summaria,Roberto Patrizi,Ambra Borghi,Cristian Di Russo,Claudio Moretti,Pierfrancesco Agostoni,Paolo Loschiavo,Ernesto Lioy,Imad Sheiban,Giuseppe Sangiorgi +15 more
TL;DR: Radial access in patients with ST-segment elevation acute coronary syndrome is associated with significant clinical benefits, in terms of both lower morbidity and cardiac mortality, and should become the recommended approach in these patients, provided adequate operator and center expertise is present.
Journal ArticleDOI
A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease.
Giuseppe Biondi-Zoccai,Marzia Lotrionte,Pierfrancesco Agostoni,Antonio Abbate,Massimiliano Fusaro,Francesco Burzotta,Luca Testa,Imad Sheiban,Giuseppe Sangiorgi +8 more
TL;DR: Non-compliance or withdrawal of aspirin treatment has ominous prognostic implication in subjects with or at moderate-to-high risk for CAD and aspirin discontinuation in such patients should be advocated only when bleeding risk clearly overwhelms that of atherothrombotic events.